From biopharma and therapeutics to life sciences and robotics—and much, much more—the Penn Center for Innovation touches it all. The Center, created in 2014, thrives by being the University’s one-stop-shop for commercialization and entrepreneurship.
This past year has been one for the books. The Center this week presented its fiscal 2018 “Year in Review,” showcasing its achievements in commercial activities. Penn Today took a dive into some of the report’s most significant numbers.
359
Penn faculty members submitted inventions for review
801
patents filed
679
commercial agreements executed
$69.4 million
in licensing income
$109.8 million
in revenue received from industry-sponsored research agreements
Penn physicists led by Bo Zhen have created hybrid light-matter particles that interact strongly enough to compute, pointing toward ultrafast, low-energy optical AI hardware.
Penn’s newest supercomputer is transforming research
Penn’s first campus-wide HPC and AI cluster, “Betty,” is expanding access to powerful computing, enabling groundbreaking projects, and fostering new collaborations across disciplines.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
The performing arts at Penn: Process, practice, and purpose
In the vivid tapestry of performing arts groups at Penn, students prepare for their performances while simultaneously enriching their college experience.
